Global Low Molecular Weight Heparin Market Data Survey Report 2025
- HEY2268065
- 87 Pages
- November 2017
- Healthcare
Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage. Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.
The global Low Molecular Weight Heparin market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
Major applications as follows:
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Aspen
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Sanofi-aventis
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Pfizer
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Opocrin
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 CSBIO
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Dongying Tiandong Pharmaceutical
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Changzhou Qianhong Bio-pharma
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Techdow
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Yantai Dongcheng Pharmaceutical Group
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Treatment of Venous Thromboembolism
4.1.1 Overview
4.1.2 Treatment of Venous Thromboembolism Market Size and Forecast
4.2 Complications of Pregnancy
4.2.1 Overview
4.2.2 Complications of Pregnancy Market Size and Forecast
4.3 Cardioversion of Atrial Fibrillation/Flutter
4.3.1 Overview
4.3.2 Cardioversion of Atrial Fibrillation/Flutter Market Size and Forecast
4.4 Others
4.4.1 Overview
4.4.2 Others Market Size and Forecast
5 Market Price
5.1 Overview
5.2 Price by SUK
6 Conclusion
List Of Tables
Tab Regional Production 2011-2017 (Value)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Aspen
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofi-aventis
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Volume, Price, Cost and Margin of Opocrin
Tab Sales Revenue, Volume, Price, Cost and Margin of CSBIO
Tab Sales Revenue, Volume, Price, Cost and Margin of Dongying Tiandong Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of Changzhou Qianhong Bio-pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Techdow
Tab Sales Revenue, Volume, Price, Cost and Margin of Yantai Dongcheng Pharmaceutical Group
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
List Of Figures
Fig Global Low Molecular Weight Heparin Market Size and CAGR 2011-2017 (Value)
Fig Global Low Molecular Weight Heparin Market Size and CAGR 2011-2017 (Volume)
Fig Global Low Molecular Weight Heparin Market Forecast and CAGR 2018-2025 (Value)
Fig Global Low Molecular Weight Heparin Market Forecast and CAGR 2018-2025 (Volume)
Fig Treatment of Venous Thromboembolism Market Size and CAGR 2011-2017 (Value)
Fig Treatment of Venous Thromboembolism Market Size and CAGR 2011-2017 (Volume)
Fig Treatment of Venous Thromboembolism Market Forecast and CAGR 2018-2025 (Value)
Fig Treatment of Venous Thromboembolism Market Forecast and CAGR 2018-2025 (Volume)
Fig Complications of Pregnancy Market Size and CAGR 2011-2017 (Value)
Fig Complications of Pregnancy Market Size and CAGR 2011-2017 (Volume)
Fig Complications of Pregnancy Market Forecast and CAGR 2018-2025 (Value)
Fig Complications of Pregnancy Market Forecast and CAGR 2018-2025 (Volume)
Fig Cardioversion of Atrial Fibrillation/Flutter Market Size and CAGR 2011-2017 (Value)
Fig Cardioversion of Atrial Fibrillation/Flutter Market Size and CAGR 2011-2017 (Volume)
Fig Cardioversion of Atrial Fibrillation/Flutter Market Forecast and CAGR 2018-2025 (Value)
Fig Cardioversion of Atrial Fibrillation/Flutter Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Value)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Value)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
